PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Valuation and Targets, page-224

  1. 815 Posts.
    lightbulb Created with Sketch. 62
    Fundies are watching, they will get in once all approvals are in place and revenue can be forecasted. We are the early birds!!! Wait until revenues come in, PAR will be selected as a growth and defensive play, can't go wrong there.
    Only real risk is a take over, which is probable in my view.
    Last edited by GreatMinds: 16/12/19
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.